| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |